Impact of aging on high-dose inhaled corticosteroid use and specialist care management in patients with asthma: a Danish nationwide cohort study
The prevalence of high- and supratherapeutic ICS exposure was higher among patients ≥56 years, and when exceeding 76 years of age, a smaller proportion were managed in secondary care. With an increased focus on adverse effects of high-dose ICS treatment and earlier initiation of other treatments, our findings will, hopefully, facilitate less age inequity in asthma management.
Authors
- Howraman Meteran (ORCID: https://orcid.org/0000-0001-5994-8064)
- Peter Ascanius Jacobsen (ORCID: https://orcid.org/0000-0001-6083-7441)
- Kjell Erik Julius Håkansson (ORCID: https://orcid.org/0000-0001-5804-0740)
- Ulla Møller Weinreich (ORCID: https://orcid.org/0000-0003-1975-3654)
- Alma Holm Rovsing
- Erik Sören Halvard Hansen
- Charlotte Suppli Ulrik
- Nicklas Brustad
Institutions
- University of Copenhagen (DK)
- Aalborg University Hospital (DK)
- Bispebjerg Hospital (DK)
- Hvidovre Hospital (DK)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
- Copenhagen Prospective Studies on Asthma in Childhood (DK)
- Aalborg University (DK)
Publication Details
- Journal
- Journal of Asthma
- Published
- 2026-03-17
- DOI
- https://doi.org/10.1080/02770903.2026.2644873
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00